Literature DB >> 19549670

Antibiotic use and intussusception in early childhood.

Anders Hviid1, Henrik Svanström.   

Abstract

OBJECTIVES: Antibiotic use in childhood has been hypothesized to increase the risk of intussusception. Antibiotics have well-known effects on gut motility and microflora-possible mechanisms for the hypothesized association. We evaluated the risk of intussusception according to antibiotic use.
METHODS: We conducted a nationwide cohort study of all Danish singleton children born between 1995 and 2003 (n = 611 410) with individual-level information on antibiotic prescriptions, intussusception and potential confounding variables. Using Poisson regression, we estimated rate ratios of intussusception according to antibiotic use, including estimating increases in rate ratios per dose of antibiotics and rate ratios for time periods following antibiotic use.
RESULTS: Intussusception was diagnosed in 434 children during 1 180 749 person-years of follow-up. The intussusception rate ratio was 1.51 [95% confidence interval (CI), 1.19-1.91] comparing antibiotic users with non-users. In the first week following use of extended-spectrum penicillins the rate ratio was 4.68 (95% CI, 2.93-7.47). In the first week following use of macrolides the rate ratio was 3.82 (95% CI, 1.22-11.90). The proportion of all cases attributable to extended-spectrum penicillins and macrolides was 4%.
CONCLUSIONS: This is the first prospective study to show an association between antibiotics and intussusception. The association was strong, temporal and biologically plausible. The magnitude of the observed effect and a number of sensitivity analyses favour a causal relationship. However, the potential for confounding-by-indication cannot be completely discounted and controlled studies of the observed association will be necessary for more definite confirmation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549670     DOI: 10.1093/jac/dkp217

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Fetal safety of macrolides.

Authors:  Anat Bahat Dinur; Gideon Koren; Ilan Matok; Arnon Wiznitzer; Elia Uziel; Rafael Gorodischer; Amalia Levy
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

2.  Reply letter and clarifications on behalf of La Rosa and colleagues to Sicilian Public Health Authorities.

Authors:  Francesco La Rosa; Grasso Chiara; Valeria La Rosa; Valentina Taranto; Concetta Maria Spinello; Giuseppa La Camera; Marinella Astuto
Journal:  Hum Vaccin Immunother       Date:  2016-08-23       Impact factor: 3.452

Review 3.  Management for intussusception in children.

Authors:  Steven Gluckman; Jonathan Karpelowsky; Angela C Webster; Richard G McGee
Journal:  Cochrane Database Syst Rev       Date:  2017-06-01

4.  Precise reply and clarifications on behalf of Sicilian Public Health Authorities to the case report published by La Rosa and collegues.

Authors:  Francesco Vitale; Claudio Costantino; Vincenzo Restivo; Nicolò Casuccio; Giovanni Corsello; Mario Palermo; Ignazio Tozzo
Journal:  Hum Vaccin Immunother       Date:  2016-08-25       Impact factor: 3.452

5.  Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage.

Authors:  Claudio Costantino; Vincenzo Restivo; Fabio Tramuto; Alessandra Casuccio; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2018-06-22       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.